No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
CA Stock MarketDetailed Quotes
FRX Fennec Pharmaceuticals Inc
- 8.570
- +0.110+1.30%
15min DelayMarket Closed Dec 20 16:00 ET
235.09MMarket Cap-158.70P/E (TTM)
8.570High8.470Low5.80KVolume8.480Open8.460Pre Close49.20KTurnover15.43052wk High0.03%Turnover Ratio27.43MShares5.65052wk Low-0.054EPS TTM161.19MFloat Cap391.500Historical HighLossP/E (Static)18.81MShs Float0.270Historical Low-0.795EPS LYR1.18%Amplitude--Dividend TTM-31.74P/B1Lot Size--Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Fennec's Pedmarqsi Gets Nod From U.K. Regulators
Craig-Hallum Initiates Fennec Pharmaceuticals(FENC.US) With Buy Rating
Wedbush Keeps Outperform, US$13 Target on Fennec After UK's National Institute Draft Guidance
Craig-Hallum Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating
Fennec Gets "Positive Recommendation" for Pedmarqsi Use in England and Wales
Fennec's PEDMARQSI Gains National Institute for Health and Care Excellence Support, Offers Hope for Young Patients
Heat List
CA
Overall
Symbol
Price
% Chg
No Data